In vivo RNAi for target validation in oncology

被引：0
|
作者：
Seibler, Jost
Ewa, Michalak
Karim, Nacerddine
van Lohuizen, Maarten
Jos, Jonkers
机构：
[1] TaconicArtemis GmbH, Cologne, Germany
[2] Netherlands Canc Inst, Div Mol Biol, Amsterdam, Netherlands
来源：
BULLETIN DU CANCER | 2010年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [31] Developing a CRISPR In Vivo Platform to Expedite Drug Target Validation
    Lo, Shih-Ching
    Pettmann, Brigitte
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 410 - 410
  • [32] RNAi: Towards in vivo therapy
    Lieberman, J
    [J]. ANTIVIRAL THERAPY, 2004, 9 (06) : H5 - H5
  • [33] In vivo RNAi: Today and Tomorrow
    Perrimon, Norbert
    Ni, Jian-Quan
    Perkins, Lizabeth
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (08): : a003640
  • [34] Electrotransfer of RNAi-based Oligonucleotides for Oncology
    Chabot, Sophie
    Pelofy, Sandrine
    Paganin-Gioanni, Aurelie
    Teissie, Justin
    Golzio, Muriel
    [J]. ANTICANCER RESEARCH, 2011, 31 (12) : 4083 - 4089
  • [35] Role of ADME in supporting an in vivo target inhibition strategy for preclinical oncology studies
    Ott, J
    Dierks, E
    Yingling, J
    Yan, L
    Liu, Q
    McMillen, W
    Sawyer, JS
    [J]. DRUG METABOLISM REVIEWS, 2004, 36 : 100 - 100
  • [36] siRNA nanoparticles: the future of RNAi therapeutics for oncology?
    Chou, Szu-Ting
    Mixson, A. James
    [J]. NANOMEDICINE, 2014, 9 (15) : 2251 - 2254
  • [37] RNAi mediated gene silencing in primary T cells: a new approach for validation of target genes in inflammation
    Gust, T.
    Merz, C.
    Prinz, F.
    von Bonin, A.
    [J]. EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 218 - 218
  • [38] Negative Selection In Vivo RNAi Screening Identifies a Ribosomal Protein as a New Therapeutic Target in Liver Cancer
    Pesic, M.
    Wolter, K.
    Wuestefeld, T.
    Kang, T. -W.
    Chawla, R.
    Geffers, R.
    Klawonn, F.
    Malek, N.
    Schirmacher, P.
    Premsrirut, P. K.
    Longerich, T.
    Zender, L.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 100 - 100
  • [39] In vivo Osteoarthritis target validation utilizing genetically-modified mice
    Glasson, Sonya S.
    [J]. CURRENT DRUG TARGETS, 2007, 8 (02) : 367 - 376
  • [40] In vivo validation of candidate radiosensitizers that target ionizing radiation induced foci
    Efimova, Elena V.
    Mauceri, Helena J.
    Labay, Edwardine
    Sutton, Harold
    Haraf, Ashly
    Kron, Stehen J.
    Weichselbaum, Ralph
    [J]. CANCER RESEARCH, 2014, 74 (19)
12345